ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Dr. Drake on Immunotherapy Side Effects in Genitourinary Cancers – OncLive

Continue reading

2017-03-04 Michael Zand NEWS

Stellar Biotechnologies gets immunotherapy manufacturing contract – Pacific Coast Business Times

Pacific Coast Business TimesStellar Biotechnologies gets immunotherapy manufacturing contractPacific Coast Business TimesPort Hueneme immunotherapy company Stellar Biotechnologies announced an exclusive multi-year supply agreement with Taiwanese manufa… Continue reading

2017-03-04 Michael Zand NEWS

Possible U | Abeona Therapeutics using gene therapy to see the possible – WKYC-TV


OncLive

Dr. Drake on Immunotherapy Side Effects in Genitourinary Cancers
OncLive
Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the side effects associated with immunotherapy in …

Continue reading

2017-03-04 Michael Zand NEWS

Clinical-Grade Stem Cells Fail to Replicate Benefit of Research Lines – Alzforum

AlzforumClinical-Grade Stem Cells Fail to Replicate Benefit of Research LinesAlzforumIn May 2016, researchers at the now-defunct StemCells Inc., Newark, California, terminated a Phase 2 trial of neural stem cells for spinal cord injury due to lack of e… Continue reading

2017-03-04 Michael Zand NEWS

Clinical-Grade Stem Cells Fail to Replicate Benefit of Research Lines – Alzforum

AlzforumClinical-Grade Stem Cells Fail to Replicate Benefit of Research LinesAlzforumIn May 2016, researchers at the now-defunct StemCells Inc., Newark, California, terminated a Phase 2 trial of neural stem cells for spinal cord injury due to lack of e… Continue reading

2017-03-04 Michael Zand NEWS

Dr. Sabari on Future of Immunotherapy in SCLC – OncLive – OncLive

OncLiveDr. Sabari on Future of Immunotherapy in SCLC – OncLiveOncLiveJoshua Sabari, MD, medical oncology fellow, Memorial Sloan Kettering Cancer Center, discusses the future that immunotherapy has in the field of small cell …and more &raquo… Continue reading

2017-03-03 Michael Zand NEWS

CRISPR Controversy Continues Despite Patent Win for Zhang – Medscape


WKYC-TV

Possible U | Abeona Therapeutics using gene therapy to see the possible
WKYC-TV
They’re working on gene therapy, using a virus to deliver the correct DNA into each cell with a simple injection. “We are the only trial in the world right now enrolling patients in this type of disease category,” says Dr. Miller. There are 7,000 rare …
Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in ShanghaiYahoo Finance

all 9 news articles »

Continue reading

2017-03-03 Michael Zand NEWS

Immunotherapy: Training the Body to Fight Cancer – U.S. News & World Report


Medscape

CRISPR Controversy Continues Despite Patent Win for Zhang
Medscape
LA JOLLA, California — In his first public presentation since he was awarded a contested patent for CRISPR gene-editing technology, Feng Zhang, PhD, from the Broad Institute of MIT and Harvard University in Cambridge, did not address the controversial …
USAgulfnews.com

all 2 news articles »

Continue reading

2017-03-03 Michael Zand NEWS
  • 1
  • …
  • 2,020
  • 2,021
  • 2,022
  • 2,023
  • 2,024
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

U.S. News & World Report

Immunotherapy: Training the Body to Fight Cancer
U.S. News & World Report
Immunotherapy treatments are not “one size fits all.” Different patients will respond better to different treatments, and some cancers may not respond at all. Identifying specific changes in tissue that can be monitored, called biomarkers, to predict …